NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Koninklijke DSM N.V (OTCQX: RDSMY)

RDSMY Technical Analysis
As on 11th Nov 2022 RDSMY STOCK Price closed @ 33.85 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 49.83 & Strong Sell for SHORT-TERM with Stoploss of 47.56 we also expect STOCK to react on Following IMPORTANT LEVELS.


Open 33.22 Change Price %
High 33.90 1 Day 1.08 3.30
Low 33.11 1 Week 5.82 20.76
Close 33.85 1 Month 5.78 20.59
Volume 56600 1 Year -12.00 -26.17
52 Week High 56.67 | 52 Week Low 27.12
OTCQX USA Most Active Stocks
OREAF 0.02 %
RHHBY 39.15 %
GBTC 13.54 %
ETHE 7.80 %
EMHTF 0.04 33.33%
VYGVF 0.15 -6.25%
ZNOG 0.08 %
DANOY 11.58 %
LGDTF 0.31 %
CURLF 2.96 %
OTCQX USA Top Gainers Stocks
VVCIF 0.02 100.00%
EMHTF 0.04 33.33%
POPRF 0.50 28.57%
POPRF 0.50 28.57%
LONE 16.00 6.24%
FTSSF 0.24 4.35%
CRTPF 3.41 4.28%
GRFXY 1.23 4.24%
AAZZF 5.45 4.21%
ALVOD 3.65 3.69%
OTCQX USA Top Losers Stocks
AKOWF 0.05 -76.19%
ZNOGW 1.05 -19.23%
IDAID 4.11 -11.61%
MTENY 0.28 -9.68%
WDDMF 0.12 -7.69%
WPTIF 20.10 -7.59%
WOWMF 1.12 -7.44%
VQSLF 2.50 -7.06%
VYGVF 0.15 -6.25%
VQS 2.73 -6.25%
Daily Charts
Intraday Charts
Whats New @
Free Analysis
RDSMY Important Levels Intraday
RDSMY Forecast December 2023
4th UP Forecast45.78
3rd UP Forecast41.95
2nd UP Forecast39.59
1st UP Forecast37.22
1st DOWN Forecast30.48
2nd DOWN Forecast28.11
3rd DOWN Forecast25.75
4th DOWN Forecast21.92
RDSMY Weekly Forecast
4th UP Forecast35.93
3rd UP Forecast35.26
2nd UP Forecast34.85
1st UP Forecast34.44
1st DOWN Forecast33.26
2nd DOWN Forecast32.85
3rd DOWN Forecast32.44
4th DOWN Forecast31.77
RDSMY Forecast2023
4th UP Forecast92.28
3rd UP Forecast73.54
2nd UP Forecast61.96
1st UP Forecast50.37
1st DOWN Forecast17.33
2nd DOWN Forecast5.74
3rd DOWN Forecast-5.84
4th DOWN Forecast-24.58
RDSMY Other Details
Segment EQ
Market Capital 38844440576.00
Sector Basic Materials
Industry Specialty Chemicals
Offical website >
RDSMY Address
RDSMY Latest News
Your Comments and Response on Koninklijke DSM N.V
RDSMY Business Profile
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, enzymes, eubiotics, carotenoids, lipids, and minerals; human nutrition and health products comprising carotenoids, digestive enzymes, nutritional lipids, nutraceuticals, probiotic and prebiotics, human milk oligosaccharides, and vitamins, as well as premix, market-ready solutions, and personalized nutrition; and skin and sun care, hair care, and aroma ingredients. It also provides vitamin and lipid active pharmaceutical ingredients; omega-3 fatty acids; specialty food enzymes, cultures, probiotics, bio-preservation, sugar reduction, and savory taste solutions; and specialty hydrocolloid solutions. The Materials segment provides thermoplastics used in automotive, electrical and electronics, building and construction, medical, food packaging, and consumer goods; and Dyneema, a fiber solution for use in ropes and lines, and outdoor and sports applications. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, plastic and reconstructive surgery, soft tissue, and wound management. It also provides yeast and enzymes for the conversion of starch, corn fiber, and biomass. Koninklijke DSM N.V. has a strategic partnership with Mile High Labs, LLC to develop and commercialize science-backed cannabinoid consumer products. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands. Address: Het Overloon 1, Heerlen, Netherlands, 6411 TE
2005-2023 All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service